Rhythm Pharmaceuticals Stock Technical Analysis

RYTM Stock  USD 65.58  1.75  2.60%   
As of the 11th of November 2024, Rhythm Pharmaceuticals holds the Coefficient Of Variation of 510.27, risk adjusted performance of 0.1563, and Semi Deviation of 2.07. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rhythm Pharmaceuticals, as well as the relationship between them. Please check Rhythm Pharmaceuticals market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Rhythm Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 65.58 per share. Given that Rhythm Pharmaceuticals has jensen alpha of 0.2781, we recommend you to check out Rhythm Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Rhythm Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Rhythm, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Rhythm
  
Rhythm Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Rhythm Pharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
40.78Strong Buy11Odds
Rhythm Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Rhythm analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Rhythm stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Rhythm Pharmaceuticals, talking to its executives and customers, or listening to Rhythm conference calls.
Rhythm Analyst Advice Details
Rhythm Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Rhythm Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rhythm Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Rhythm Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Rhythm Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Rhythm Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Rhythm Pharmaceuticals. You can use it to identify possible trend reversals for Rhythm Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Rhythm Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Rhythm Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Rhythm Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.17  , which means Rhythm Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1072.2, which is the sum of squared deviations for the predicted Rhythm Pharmaceuticals price change compared to its average price change.

About Rhythm Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Rhythm Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Rhythm Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Rhythm Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Rhythm Pharmaceuticals. By analyzing Rhythm Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Rhythm Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Rhythm Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 (projected)
Payables Turnover0.441.92.0
Days Of Inventory On Hand499.16338.4241.38

Rhythm Pharmaceuticals November 11, 2024 Technical Indicators

Most technical analysis of Rhythm help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rhythm from various momentum indicators to cycle indicators. When you analyze Rhythm charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Rhythm Pharmaceuticals November 11, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Rhythm stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Rhythm Pharmaceuticals is a strong investment it is important to analyze Rhythm Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rhythm Pharmaceuticals' future performance. For an informed investment choice regarding Rhythm Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.32)
Revenue Per Share
1.863
Quarterly Revenue Growth
0.478
Return On Assets
(0.46)
Return On Equity
(1.48)
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.